Notably, glutamine reportedly stabilizes c‐MYC via α‐ketoglutarate to prevent c‐MYC degradation through the ubiquitination–proteosomal pathway, thus weakening the sensitivity of pancreatic cancer cells to paclitaxel.49 Here, MYC is linked to familial pancreatic carcinoma.